Mosaic ImmunoEngineering Inc.
CPMV· OTC
CPMVMosaic ImmunoEngineering Inc.
Filed Nov 19, 2024 · 10-Q · 50 days after period end · 0001683168-24-008258
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$186.73K | -$333.25K | -$153.65K | -$1.05M |
| EPS Diluted | -$0.03 | -$0.05 | -$0.02 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 19, 2024 · 50 d after period end
